Girma J P, Pietu G, Lavergne J M, Meyer D, Larrieu M J
J Lab Clin Med. 1982 Apr;99(4):481-94.
Antibodies specific for either the subunit (MW 2.4 X 10(5)) or conformational antigenic determinants of F.VIII/vWF were prepared in order to investigate further the abnormal antigenic reactivity in variants of vWD. Goat anti-human F.VIII/vWF Fab fragments were immunoadsorbed with F.VIII/vWF subunits bound to activated thiol-Sepharose, and the "anti-subunit" antibody was eluted at pH 2.4. Antibodies that did not bind to the beads were designated as "anti-conformation" antibody. The anti-subunit specifically reacted by IRMA with the F.VIII/vWF subunits and with all subunit-containing multimers (MW 4.8 X 10(5) to greater than 15 X 10(6)). The anti-conformation antibody failed to react with F.VIII/vWF subunits but reacted with native (MW 1 to greater than 15 X 10(6)) or partially reduced (MW 4.8 X 10(5)) F.VIII/vWF. It was thus specific for antigenic sites resulting from the association of subunits in dimers or multimers of F.VIII/vWF. In eight patients with a variant of vWD (type IIA), an abnormal antigenic reactivity in plasma, characterized by a dose-response curve not parallel to that of control, was consistently observed by IRMA using the anti-subunit antibody. Six showed a normal dose-response curve with the anti-conformation antibody, and two unique patients also demonstrated an abnormal (nonparallel) response. This study (1) allows the distinction between subunit and conformational antigenic sites on F.VIII/vWF, (2) demonstrates that the decreased antigenicity in type IIA vWD is associated in all cases with an abnormality of F.VIII/vWF subunits and in some patients with an additional defect of polymerization, and (3) further emphasizes the heterogeneity of variants of vWD.
制备了针对F.VIII/vWF亚基(分子量2.4×10⁵)或构象抗原决定簇的特异性抗体,以便进一步研究血管性血友病(vWD)变异体中的异常抗原反应性。将山羊抗人F.VIII/vWF Fab片段用结合到活化巯基-琼脂糖上的F.VIII/vWF亚基进行免疫吸附,“抗亚基”抗体在pH 2.4时洗脱。未与珠子结合的抗体被指定为“抗构象”抗体。抗亚基通过免疫放射分析(IRMA)与F.VIII/vWF亚基以及所有含亚基的多聚体(分子量4.8×10⁵至大于15×10⁶)特异性反应。抗构象抗体不与F.VIII/vWF亚基反应,但与天然的(分子量1至大于15×10⁶)或部分还原的(分子量4.8×10⁵)F.VIII/vWF反应。因此,它对F.VIII/vWF二聚体或多聚体中亚基缔合产生的抗原位点具有特异性。在8例vWD变异体(IIA型)患者中,使用抗亚基抗体通过IRMA始终观察到血浆中异常的抗原反应性,其特征为剂量反应曲线与对照不平行。6例患者使用抗构象抗体显示正常的剂量反应曲线,2例特殊患者也表现出异常(不平行)反应。本研究(1)能够区分F.VIII/vWF上的亚基和构象抗原位点,(2)表明IIA型vWD中抗原性降低在所有病例中都与F.VIII/vWF亚基异常有关,在一些患者中还与聚合的额外缺陷有关,(3)进一步强调了vWD变异体的异质性。